F
Fantasy VC
Fantasy VCSign in
DiscoverMarketsPortfolioActivity
F
Fantasy VCCommunity is the asset
Fantasy VC
DiscoverMarketsPortfolioActivity
SettingsHow it works
Sign in
F
Fantasy VC
Fantasy VC
DiscoverMarketsPortfolioActivity
Sign in
F
Fantasy VC
Fantasy VCSign in
Markets
BH

Brian Heligman

Biosphere
@BrianTHeligman3.2K followersBay Area, CA

Co-founder and CEO of Biosphere, the first UV-sterilized bioreactor company.

Co-founder and CEO of Biosphere, the first UV-sterilized bioreactor company.

Price
$20.00
▼-82.20%today
Last raised$8.8M·Seed·May 2026
Newstaller pin = bigger storyTap a pin to see headlines + price impact
Volume 24h
$349.2K
Holders
1,696
7d change
-81.90%

News

·600
+0.03
IN
Obscure 90s science experiment mentioned in passing
Inbox.eu · 1h ago
LA
Brian Heligman participates in Lanzarote water conservation event
La Voz de Lanzarote · 2h ago

Recent trades

·0
No recent trades.

Career

  1. 2022–present
    Co-founder & CEO · Biosphere
    Raised $8.8M seed; launched UV-sterilized bioreactor; won DoD contract.
  2. 2020–2022
    Postdoctoral Researcher · UT Austin
    Materials science research before founding Biosphere.

About

Brian Heligman is a materials scientist and the co-founder/CEO of Biosphere, an Oakland startup rethinking the unit economics of biomanufacturing.

Accomplishments

  • Co-founded Biosphere in 2022 to build UV-sterilized bioreactors
  • Raised $8.8M seed led by Lowercarbon and VXI with Founders Fund participation
  • Won $1.5M U.S. Department of Defense contract for bioproduction
  • Pioneered first commercial bioreactor sterilized entirely by UV LED light
  • PhD materials scientist, formerly postdoc at UT Austin

Pricing breakdown

Accomplishments15 · 35%
Funding · $8.8M raised
Mainstream popularity18 · 25%
Social popularity27 · 25%
X · 3.2K followers · 2.0 tweets/day · verified
Net worth27 · 15%
Composite
20/100
Intrinsic
$20.00
Market
+0.00%

Intrinsic price is set by the four-factor fundamentals score (35/25/25/15). Market price floats around it via a constant-product AMM — every trade moves the curve.

Tags

biotechmanufacturinghardwareclimate